Antinociceptive effect of lidocaine in rats

Pharmacological Reports

Volumn 58, Issue 6, 2006, Pages 961-965

  Rykaczewska Czerwińska, Monika ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Intracerebroventricular administration; Lidocaine; Pain; Rat

Indexed keywords

LIDOCAINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; HOT PLATE TEST; LATENT PERIOD; MALE; MEDICINE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; RAT; THERMAL STIMULATION;

EID: 33846318559     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abed WT: Alterations of lidocaine and pentylenetetrazol-induced convulsions by manipulation of brain monoamines. Pharmacol Toxicol, 1994, 75, 162-165.
2. Beckh S: Differential expression of sodium channel mRNAs in rat peripheral nervous system and innervated tissues. FEBS Lett, 1990, 262, 317-322.
3. Black JA, Yokoyama S, Higashida H, Ransom BR, Waxman SG: Sodium channel mRNAs I, II and III in the CNS: cell specific expression. Brain Res Mol Brain Res, 1994, 22, 275-289.
4. Cahana A, Carota A, Montadon ML, Artnoni JM: The long-term effect of repeated intravenous lidocaine on central pain and possible correlation in positron emission tomography measurements. Anesth Analg, 2004, 98, 1581-1584.
5. Canastaneda-Castellanos DR, Nikonorov I, Kallen RG, Recio-Pinto E: Lidocaine stabilizes the open state of CNS voltage-dependent sodium channels. Brain Res Mol Brain Res, 2002, 99, 102-113.
6. Catterall WA: From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels. Neuron, 2000, 26, 13-25.
7. + channel blockers in two rat models of neuropathic pain. Eur J Pharmacol, 2003, 458, 275-282.
8. Gautron S, Dos Santos G, Pinto- Henrique D, Koulakoff A, Gross F, Bervald-Netter Y: The glial voltage-gated sodium channel: cell- and tissue-specific mRNA expression. Proc Natl Acad Sci USA, 1992, 89, 7272-7276.
9. Gibiec S, Plech A: Study on neurotoxic effects of lidocaine. Pol J Pharmacol 1998, 50, 166.
10. + currents in rat sensory neurons in vitro. J Pharmacol Exp Ther, 2001, 299, 705-711.
11. Janssen PAJ, Niemegeers CJE, Dony JGH: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm-water induced tail withdrawal reflex in rats. Arzneim Forsch-Drug Res, 1963, 13, 502-507.
12. Kilian M, Frey HH: Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology, 1973, 12, 681-692.
13. Leuwer M, Haeseler G, Hecker H, Bufler R, Aronson JK: An improved model for the binding of lidocaine and structurally related local anaesthetics to fast-inactivated voltage-operated sodium channels, slowing evidence of cooperativity. Br J Pharmacol, 2004, 141, 47-54.
14. Linas R, Yarom Y: Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurons in vitro. J Physiol, 1981, 315, 569-584.
15. McKenna JE, Melzack R: Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain, 1992, 49, 105-112.
16. 3H]Batrachotoxin-A 20α-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs. J Med Chem, 1985, 28, 381-388.
17. Ness TJ: Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat. Anesthesiology, 2000, 92, 1685-1691.
18. O'Callaghan JP, Holtzman SG: Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther, 1975, 192, 497-505.
19. Plech A, Rykaczewska-Czerwińska M, Bartosz-Bechowski H, Lombarska-Śliwińska D, Małota M, Szewczyk M, Brus R et al.: Insect neuropeptide leucopyrokinin (LPK, or Lem-PK) analoques - synthesis and antinociceptive effect in rats. Pol J Pharmacol, 1997, 49, 119-126.
20. Plech A, Klimkiewicz T, Maksym B: effect of L-arginine on memory in rats. Pol J Pharmacol, 2003, 55, 987-992.
21. Sandtner W, Szendroedi J, Zarrabi T, Zebedin E, Hilber K, Glaaser I, Fozzard HA et al.: Lidocaine: a foot in the door of the inner vestibule prevents ultra-slow inactivation of a voltage-gated sodium channel. Mol Pharmacol, 2004, 6, 648-657.
22. Sindrup SH: Treatment of the symptoms of diabetic neuropathy. Pain Dig, 1993, 3, 7-14.
23. Sokoła A, Plech A: Effect of toxic doses of lidocaine on dopamine metabolism in rat striatum. Pol J Pharmacol, 2004, 56, Suppl. 197.
24. Sorensen J, Bengtsson A, Backman E, Henriksson KG, Bengtsson M: Pain analysis in patients with fibromyalgia: Effect of intravenous morphine, lidocaine and ketamine. Scand J Rheumatol, 1995, 24, 360-365.
25. Strichartz G: Molecular mechanism of nerve block by local anaesthetics. Anaesthesiology, 1976, 45, 421-441.
26. Xu F, Garativo-Aguilar Z, Recio-Pinto E, Zhang JJ, Blanck TJ: Local anesthetics modulate neuronal calcium signaling through multiple sites of action. Anesthesiology, 2003, 98, 1139-1146.
27. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 1983, 16, 109-110.